{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-170277","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2022-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.618289+00:00","generated_at":"2026-06-25T03:28:54.450869+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aileron Therapeutics fails to regain Nasdaq bid price compliance; granted extension to Dec 5, 2022","bullets":["Received deficiency notice Dec 2021 for bid price below $1.00; initial 180-day period ended June 6, 2022 without compliance.","Nasdaq granted additional 180-day period until Dec 5, 2022 to cure, conditional on meeting other listing requirements.","Company intends to cure deficiency by effecting a reverse stock split if necessary.","If compliance not achieved by Dec 5, 2022, Nasdaq will issue delisting notification; Company may appeal to Listing Qualifications Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-170277","json":"https://secwatch.observer/filing/0001193125-22-170277.json","markdown":"https://secwatch.observer/filing/0001193125-22-170277.md","text":"https://secwatch.observer/filing/0001193125-22-170277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312522170277/0001193125-22-170277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312522170277/d368711d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:28:54.450869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}